FDA Approves Novel Pandemic Influenza Vaccine FDA Approves Novel Pandemic Influenza Vaccine

Audenz (Seqirus) is the first and only adjuvanted, cell-based pandemic vaccine to provide active immunization against the influenza A virus H5N1 strain.FDA Approvals

Source: Medscape Pharmacist Headlines - February 4, 2020 Category: Drugs & Pharmacology Tags: Infectious Diseases News Alert Source Type: news